{"id":"https://openalex.org/W4240544729","doi":"https://doi.org/10.2337/figshare.12493493","title":"Factors Contributing to the Rising National Cost of Glucose-Lowering Medicines for Diabetes During 2005\u20132007 and 2015\u20132017","display_name":"Factors Contributing to the Rising National Cost of Glucose-Lowering Medicines for Diabetes During 2005\u20132007 and 2015\u20132017","publication_year":2020,"publication_date":"2020-07-31","ids":{"openalex":"https://openalex.org/W4240544729","doi":"https://doi.org/10.2337/figshare.12493493"},"language":"en","primary_location":{"id":"doi:10.2337/figshare.12493493","doi":"https://doi.org/10.2337/figshare.12493493","is_oa":true,"landing_page_url":"https://doi.org/10.2337/figshare.12493493","pdf_url":null,"source":null,"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Diabetes Association","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.2337/figshare.12493493","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Xilin Zhou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xilin Zhou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014375279","display_name":"Sundar S. Shrestha","orcid":"https://orcid.org/0000-0001-6984-3522","observed_orcids":["https://orcid.org/0000-0001-6984-3522"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sundar S. Shrestha","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079095481","display_name":"Hui Shao","orcid":"https://orcid.org/0000-0002-4088-546X","observed_orcids":["https://orcid.org/0000-0002-4088-546X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hui Shao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Ping Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ping Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.5473999977111816,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.5473999977111816,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.31619998812675476,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","score":0.06710000336170197,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.7329999804496765},{"id":"https://openalex.org/keywords/glucose-lowering-medications","display_name":"glucose-lowering medications","score":0.9909999966621399},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.6489999890327454},{"id":"https://openalex.org/keywords/insulin-analogs","display_name":"insulin analogues","score":0.7860000133514404},{"id":"https://openalex.org/keywords/insulin","display_name":"insulin","score":0.6570000052452087},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9409999847412109},{"id":"https://openalex.org/keywords/cost-decomposition","display_name":"cost decomposition","score":0.5090000033378601},{"id":"https://openalex.org/keywords/cost-containment","display_name":"cost containment","score":0.39399999380111694}],"concepts":[{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6753754019737244},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6702618598937988},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.5656718015670776},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5405437350273132},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.520149290561676},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4698820412158966},{"id":"https://openalex.org/C2780777579","wikidata":"https://www.wikidata.org/wiki/Q6806347","display_name":"Medical Expenditure Panel Survey","level":4,"score":0.44534415006637573},{"id":"https://openalex.org/C2983635472","wikidata":"https://www.wikidata.org/wiki/Q334911","display_name":"Health insurance","level":3,"score":0.12959569692611694},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.09063968062400818},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.0},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/figshare.12493493","doi":"https://doi.org/10.2337/figshare.12493493","is_oa":true,"landing_page_url":"https://doi.org/10.2337/figshare.12493493","pdf_url":null,"source":null,"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Diabetes Association","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.2337/figshare.12493493","doi":"https://doi.org/10.2337/figshare.12493493","is_oa":true,"landing_page_url":"https://doi.org/10.2337/figshare.12493493","pdf_url":null,"source":null,"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Diabetes Association","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2748952813","https://openalex.org/W4391375266","https://openalex.org/W2520648843","https://openalex.org/W1920632900","https://openalex.org/W2105403615","https://openalex.org/W2904715359","https://openalex.org/W2350706782","https://openalex.org/W4380836775","https://openalex.org/W2529083239","https://openalex.org/W3144179538"],"abstract_inverted_index":{"OBJECTIVE":[0],"We":[1,52],"examined":[2],"changes":[3],"in":[4,34,94,163,170,175,184,194,214,245],"glucose-lowering":[5,37,102,198],"medication":[6,60],"spending":[7,35,58,100,165,196],"and":[8,41,66,68,75,90,112,119,152,216,220],"quantified":[9,82],"the":[10,25,32,54,83,86,126,139,161,168,173,176,185,201,208,227,232,236,243],"magnitude":[11],"of":[12,56,88,109,145,160,178,187,229],"factors":[13,233],"that":[14],"are":[15],"contributing":[16,234],"to":[17,235,241],"these":[18],"changes.":[19],"RESEARCH":[20],"DESIGN":[21],"AND":[22],"METHODS":[23],"Using":[24],"Medical":[26],"Expenditure":[27],"Panel":[28],"Survey,":[29],"we":[30,81],"estimated":[31],"change":[33],"on":[36,101,197],"medications":[38,103,114,150,157,199],"during":[39,200],"2005\u20132007":[40],"2015\u20132017":[42],"among":[43],"adults":[44],"aged":[45],"18":[46],"years":[47],"or":[48],"older":[49,156],"with":[50,131,207],"diabetes.":[51],"decomposed":[53],"increase":[55,127,140,162,169,174,193,237],"total":[57],"by":[59,64,71,85,105],"groups:":[61],"for":[62,69,148,155,211],"insulin":[63,111,164],"human":[65],"analog;":[67],"non-insulin":[70,113,189,218],"metformin,":[72],"older,":[73],"newer,":[74],"combination":[76],"medications.":[77],"For":[78,124,137],"each":[79],"group,":[80],"contributions":[84],"number":[87,177,228],"users":[89,179],"cost-per-user.":[91,171],"Costs":[92],"were":[93],"2017":[95],"US":[96],"dollars.":[97],"RESULTS":[98],"National":[99],"increased":[104,209],"$40.6":[106],"billion":[107,117,121],"(240%),":[108],"which":[110],"contributed":[115,180],"$28.6":[116],"(169%)":[118],"$12.0":[120],"(71%),":[122],"respectively.":[123],"insulin,":[125,212],"was":[128,141,204],"mainly":[129],"associated":[130,206],"higher":[132,146],"expenditures":[133],"from":[134,167],"analogs":[135,213],"(156%).":[136],"non-insulin,":[138],"a":[142,223],"net":[143],"effect":[144,225],"cost":[147,154],"newer":[149,217],"(+88%)":[151],"decreased":[153],"(-34%).":[158],"Most":[159],"came":[166],"However,":[172],"more":[181],"than":[182,226],"cost-per-user":[183,221],"rise":[186],"most":[188],"groups.":[190],"CONCLUSIONS":[191],"The":[192],"national":[195],"past":[202],"decade":[203],"mostly":[205],"costs":[210],"particular,":[215],"medicines;":[219],"had":[222],"larger":[224],"users.":[230],"Understanding":[231],"helps":[238],"identify":[239],"ways":[240],"curb":[242],"growth":[244],"costs.":[246]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2025-10-10T00:00:00"}